| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.088 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.026 | 0.6 |